MedTrace Logo

Pregabalin Reduce the Sevoflurane Requirement

NCT01571804 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2012-05-07

No results posted yet for this study

Summary

Preoperative administration of pregabalin would reduce the end tidal concentration of sevoflurane during laparoscopic cholecystectomy with added beneficial improving of the quality of postoperative analgesia.

Conditions

  • Elective Laparoscopic Cholecystectomy
  • Sevoflurane Anesthesia

Interventions

DRUG

Placebo

to receive two identical placebo capsules 1 hr before surgery

DRUG

pregabalin

one capsule of pregabalin 150 mg and one placebo capsule 1 hr before surgery

DRUG

pregabalin

two capsules of pregabalin 150 mg 1 hr before surgery

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2012-02-29
Completion
2012-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01571804 on ClinicalTrials.gov